SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 134 filers reported holding SAGE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $38,064,000 | +190.3% | 440,000 | +198.7% | 0.41% | -18.2% |
| Q4 2018 | $13,110,000 | +3582.6% | 147,315 | -65.7% | 0.50% | +7028.6% |
| Q3 2017 | $356,000 | -98.4% | 430,000 | +56.4% | 0.01% | -99.4% |
| Q2 2017 | $21,901,000 | +1014.0% | 275,000 | +37.5% | 1.10% | +883.9% |
| Q1 2017 | $1,966,000 | +68.6% | 200,000 | +900.0% | 0.11% | +30.2% |
| Q4 2015 | $1,166,000 | -31.2% | 20,000 | -50.0% | 0.09% | +26.5% |
| Q3 2015 | $1,694,000 | +16.0% | 40,000 | +100.0% | 0.07% | -22.7% |
| Q2 2015 | $1,460,000 | -58.8% | 20,000 | -71.6% | 0.09% | -68.0% |
| Q1 2015 | $3,540,000 | +37.2% | 70,484 | 0.0% | 0.28% | +27.3% |
| Q4 2014 | $2,580,000 | -60.7% | 70,484 | -66.2% | 0.22% | -69.4% |
| Q3 2014 | $6,573,000 | – | 208,676 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |